David Calianese

1.4k total citations · 1 hit paper
20 papers, 1.0k citations indexed

About

David Calianese is a scholar working on Immunology, Physiology and Molecular Biology. According to data from OpenAlex, David Calianese has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 10 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in David Calianese's work include Phagocytosis and Immune Regulation (13 papers), Erythrocyte Function and Pathophysiology (10 papers) and Autophagy in Disease and Therapy (3 papers). David Calianese is often cited by papers focused on Phagocytosis and Immune Regulation (13 papers), Erythrocyte Function and Pathophysiology (10 papers) and Autophagy in Disease and Therapy (3 papers). David Calianese collaborates with scholars based in United States, China and Belgium. David Calianese's co-authors include Raymond B. Birge, Sushil Kumar, Jay W. Carlson, Georg Schett, Bruce Freimark, Martin Herrmann, Sebastian Boeltz, Xin Huang, João Luiz Mendes Wanderley and Rolf A. Brekken and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

David Calianese

19 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer

2016 532 citations Raymond B. Birge, Sebastian Boeltz et al. Cell Death and Differentiation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Calianese United States	13	636	419	154	144	86	20	1.0k
Ricardo A. Chaurio Germany	19	618 1.0×	436 1.0×	168 1.1×	117 0.8×	49 0.6×	32	1.2k
Martina Sundqvist Sweden	19	584 0.9×	909 2.2×	80 0.5×	137 1.0×	109 1.3×	56	1.3k
Ziqi Zhang China	12	285 0.4×	484 1.2×	167 1.1×	76 0.5×	127 1.5×	26	958
Conor M. Henry Ireland	14	983 1.5×	741 1.8×	187 1.2×	144 1.0×	47 0.5×	18	1.6k
Barbara Platzer United States	19	663 1.0×	372 0.9×	105 0.7×	182 1.3×	29 0.3×	24	1.1k
Jiafeng Wang China	15	341 0.5×	370 0.9×	137 0.9×	43 0.3×	55 0.6×	31	909
Nick N. Gorgani Australia	15	513 0.8×	298 0.7×	55 0.4×	90 0.6×	63 0.7×	21	966
Nannan Zhou China	13	379 0.6×	597 1.4×	267 1.7×	51 0.4×	57 0.7×	39	1.1k
Chih-Wei Lin Taiwan	16	267 0.4×	534 1.3×	156 1.0×	189 1.3×	180 2.1×	29	1.5k

Countries citing papers authored by David Calianese

Since Specialization

Citations

This map shows the geographic impact of David Calianese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Calianese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Calianese more than expected).

Fields of papers citing papers by David Calianese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Calianese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Calianese. The network helps show where David Calianese may publish in the future.

Co-authorship network of co-authors of David Calianese

This figure shows the co-authorship network connecting the top 25 collaborators of David Calianese. A scholar is included among the top collaborators of David Calianese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Calianese. David Calianese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Calianese, David, Mariana S. De Lorenzo, Sergei V. Kotenko, et al.. (2025). Dys-regulated phosphatidylserine externalization as a cell intrinsic immune escape mechanism in cancer. Cell Communication and Signaling. 23(1). 131–131. 6 indexed citations

Davra, Viralkumar, David Calianese, Dongfang Liu, et al.. (2024). Regulation of Mertk Surface Expression via ADAM17 and γ-Secretase Proteolytic Processing. International Journal of Molecular Sciences. 25(8). 4404–4404. 6 indexed citations

Calianese, David, et al.. (2024). Expression, purification and characterization of phosphatidylserine-targeting antibodies for biochemical and therapeutic applications. Methods in cell biology. 191. 15–40.

Calianese, David, Tomoyasu Noji, Jennifer A. Sullivan, et al.. (2024). Substrate specificity controlled by the exit site of human P4-ATPases, revealed by de novo point mutations in neurological disorders. Proceedings of the National Academy of Sciences. 121(44). e2415755121–e2415755121. 3 indexed citations

Ferrara, Fortunato, Sara D’Angelo, Laura Spector, et al.. (2023). Insights into next generation sequencing guided antibody selection strategies. Scientific Reports. 13(1). 18370–18370. 12 indexed citations

Ferrara, Fortunato, Sara D’Angelo, André A. Teixeira, et al.. (2022). A pandemic-enabled comparison of discovery platforms demonstrates a naive antibody library can match the best immune-sourced antibodies. Nature Communications. 13(1). 462–462. 24 indexed citations

Palasiewicz, Karol, et al.. (2022). Phosphatidylserine externalization by apoptotic cells is dispensable for specific recognition leading to innate apoptotic immune responses. Journal of Biological Chemistry. 298(7). 102034–102034. 16 indexed citations

Hill, Amanda A., et al.. (2022). Mertk: An emerging target in cancer biology and immuno-oncology. International review of cell and molecular biology. 368. 35–59. 19 indexed citations

Badeti, Saiaditya, Alok Choudhary, Charles Reichman, et al.. (2021). CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro. Frontiers in Immunology. 12. 652223–652223. 33 indexed citations

10.

Calianese, David, Canan Kasikara, Viralkumar Davra, et al.. (2021). Phosphatidylserine-Targeting Monoclonal Antibodies Exhibit Distinct Biochemical and Cellular Effects on Anti-CD3/CD28–Stimulated T Cell IFN-γ and TNF-α Production. The Journal of Immunology. 207(2). 436–448. 2 indexed citations

11.

Davra, Viralkumar, Sushil Kumar, Ke Geng, et al.. (2020). Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity. Cancer Research. 81(3). 698–712. 61 indexed citations

12.

Calianese, David & Raymond B. Birge. (2020). Biology of phosphatidylserine (PS): basic physiology and implications in immunology, infectious disease, and cancer. Cell Communication and Signaling. 18(1). 41–41. 39 indexed citations

13.

Calianese, David, et al.. (2020). Cell Death in the Tumor Microenvironment: Implications for Cancer Immunotherapy. Cells. 9(10). 2207–2207. 29 indexed citations

14.

Kasikara, Canan, Viralkumar Davra, David Calianese, et al.. (2019). Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti–PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer. Cancer Research. 79(10). 2669–2683. 93 indexed citations

15.

Kumar, Sushil, David Calianese, & Raymond B. Birge. (2017). Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment. Immunological Reviews. 280(1). 149–164. 73 indexed citations

16.

Birge, Raymond B., Sebastian Boeltz, Sushil Kumar, et al.. (2016). Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer. Cell Death and Differentiation. 23(6). 962–978. 532 indexed citations breakdown →

17.

Davra, Viralkumar, Stanley Kimani, David Calianese, & Raymond B. Birge. (2016). Ligand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic Response. Cancers. 8(12). 107–107. 56 indexed citations

18.

Calianese, David, et al.. (2014). Alteration of metabolic activities by modulation of PI3K/AKT and mTOR pathways in ovarian cancer cells (766.10). The FASEB Journal. 28(S1). 1 indexed citations

19.

Calianese, David, Eric Still, Fang Ji, et al.. (2013). Paclitaxel disrupts polarized entry of membrane-permeable C6 ceramide into ovarian cancer cells resulting in synchronous induction of cell death. Oncology Letters. 5(6). 1854–1858. 6 indexed citations

20.

Still, Eric, et al.. (2012). N-acetylcysteine potentiates doxorubicin-induced ATM and p53 activation in ovarian cancer cells. International Journal of Oncology. 42(1). 211–218. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact